Literature DB >> 18418614

[Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report].

U Hartmann1, S Schmitt, M Reuss-Borst.   

Abstract

Elevated liver enzymes in patients with rheumatoid arthritis may have various causes. These can range from the rheumatic disease itself, the anti-rheumatic medication or be the manifestation of an associated autoimmune disease. We present the case of a 19-year-old female with known seropositive rheumatoid arthritis who developed severe liver damage after 9 months of anti-rheumatic therapy with leflunomide and adalimumab. Both drugs were stopped. In addition to the underlying disease and the specific anti-rheumatic drugs, a temporary therapy with flucloxacillin as well as an association with newly diagnosed celiac disease had to be considered as possible causes of elevated liver enzymes. Following repeated liver biopsy, autoimmune hepatitis was assumed and prednisolone and azathioprine were initiated. Elevated liver enzymes and bilirubin rapidly returned to normal values.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418614     DOI: 10.1007/s00393-008-0288-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  29 in total

1.  [Longterm outcome of TNF blockade in adult-onset Still's disease].

Authors:  C Dechant; P Schauenberg; C E Antoni; H G Kraetsch; J R Kalden; B Manger
Journal:  Dtsch Med Wochenschr       Date:  2004-06-04       Impact factor: 0.628

2.  Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.

Authors:  Stefan Russmann; James A Kaye; Susan S Jick; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

Review 3.  Adalimumab: a review of side effects.

Authors:  Noah Scheinfeld
Journal:  Expert Opin Drug Saf       Date:  2005-07       Impact factor: 4.250

4.  Sjögren's syndrome complicated with autoimmune hepatitis and antiphospholipid antibody syndrome.

Authors:  Y Katayama; K Kohriyama; K Kirizuka; H Nishizaki; H Fujii; Y Tanji
Journal:  Intern Med       Date:  2000-01       Impact factor: 1.271

Review 5.  [Liver and rheumatism].

Authors:  C Wiegard; A W Lohse
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

6.  Risk factors for development of flucloxacillin associated jaundice.

Authors:  C K Fairley; J J McNeil; P Desmond; R Smallwood; H Young; A Forbes; P Purcell; I Boyd
Journal:  BMJ       Date:  1993-01-23

7.  Autoimmune hepatitis in a patient with systemic lupus erythematosus.

Authors:  M Iwai; Y Harada; M Ishii; S Tanaka; A Muramatsu; T Mori; T Nakashima; T Okanoue; S Hirohata
Journal:  Clin Rheumatol       Date:  2003-09       Impact factor: 2.980

Review 8.  Flucloxacillin-associated hepatic injury.

Authors:  G H Koek; B H Stricker; A P Blok; S W Schalm; V J Desmet
Journal:  Liver       Date:  1994-10

Review 9.  Leflunomide in the treatment of rheumatoid arthritis.

Authors:  Edmund K Li; Lai-Shan Tam; Brian Tomlinson
Journal:  Clin Ther       Date:  2004-04       Impact factor: 3.393

10.  Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Sandra Muñoz; Natalia Soria; Diana Galiana; Laura Bertolaccini; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Medicine (Baltimore)       Date:  2007-07       Impact factor: 1.889

View more
  3 in total

1.  Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registry.

Authors:  Katja Perdan-Pirkmajer; Alojzija Hočevar; Žiga Rotar; Janez Žibert; Vera Ferlan Marolt; Filip Gučev; Matija Tomšič
Journal:  Rheumatol Int       Date:  2012-09-07       Impact factor: 2.631

2.  Hepatitis B Serology in Patients with Rheumatic Diseases.

Authors:  Martin Feuchtenberger; Arne Schäfer; Axel Philipp Nigg; Michael Rupert Kraus
Journal:  Open Rheumatol J       Date:  2016-08-31

Review 3.  Liver involvement in children with collagen vascular diseases.

Authors:  Joanna Pawłowska; Magdalena Naorniakowska; Anna Liber
Journal:  Clin Exp Hepatol       Date:  2015-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.